|Mr. Pierre Laurin B.Sc.Pharm., M.Sc.||CEO, Pres & Non-Independent Director||1.14M||N/A||57|
|Mr. Bruce Pritchard BA, CA, FioD||COO & CFO||894.49k||N/A||N/A|
|Mr. Patrick Sartore B.Sc., LLB||Chief Legal Officer & Corp. Sec.||582.25k||N/A||N/A|
|Dr. John Moran M.D., FRACP, FACP, FACPE||Chief Medical Officer & Director||629.14k||N/A||72|
|Mr. Fr??d??ric Dumais||Sr. Director of Communications & Investor Relations||N/A||N/A||N/A|
ProMetic Life Sciences Inc., a biopharmaceutical company, develops bioseparations, plasma-derived therapeutics, and small-molecule therapeutic products. The company offers its technology platform for large-scale drug purification, drug development, proteomics, and the elimination of pathogens; and develops small molecule therapeutic products targeting unmet medical needs in the fields of fibrosis, autoimmune disease/inflammation, and cancer. It operates in two segments, Small Molecule Therapeutics and Protein Technology. The Small Molecule Therapeutics segment's lead product candidate is PBI-4050, which targets unmet medical needs, such as the treatment of idiopathic pulmonary fibrosis, metabolic syndrome and its resulting type 2 diabetes, cystic fibrosis related diabetes, and Alstr??m syndrome. The Protein Technology segment provides Plasma Protein Purification System, a multi-product sequential purification process for the extraction and purification of therapeutic proteins from human plasma; bioseparation technologies and products, including Mimetic Ligand purification platform for the pharmaceutical and medical companies; and prion capture/pathogen removal technology platform that improves the safety profile of blood products and blood-derived therapeutics. The company was formerly known as Innovon Life Sciences Holdings Limited and changed its name to ProMetic Life Sciences Inc. in May 1998. ProMetic Life Sciences Inc. was founded in 1992 and is headquartered in Laval, Canada.
ProMetic Life Sciences Inc.’s ISS Governance QualityScore as of January 1, 2018 is 7. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 9; Compensation: 7.